
OrderlyMeds Review
Best for: budget-conscious shoppers
Telehealth provider offering one of the lowest 3-month starter prices for compounded GLP-1 medications.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
OrderlyMeds is one of the most affordable GLP-1 options on the market.
OrderlyMeds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $74/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored OrderlyMeds
Each dimension is scored algorithmically from OrderlyMeds’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
9.3/10At $74/mo, OrderlyMeds runs about 56% below the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.1/10OrderlyMeds offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience — consult included in the price; 3 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).
Accessibility10%
6.1/10OrderlyMeds's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.9/10OrderlyMeds provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this OrderlyMeds review
Last checked 2026-06-03- Confirmed current pricing across 3 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications OrderlyMeds offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check OrderlyMeds's current pricing and active discounts before you decide.
What we like
- Aggressively low monthly pricing
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Watch-outs
- Limited public information on program details
OrderlyMeds: the rock-bottom starter price, and the trade-offs behind it
OrderlyMeds is built around a single, blunt selling point: one of the lowest entry prices for compounded GLP-1 medication you will find anywhere. Its SimpleStart program puts your first stretch of treatment at just $74 a month, with the doctor's visit, the medication, your syringes, and shipping all rolled into that number. If your main question is 'what is the cheapest way to actually start semaglutide or tirzepatide,' OrderlyMeds answers it directly. The catch is that it asks you to trust a program that publishes very little about how it operates. For budget-conscious shoppers willing to do some homework before signing up, it can be worth a hard look. For anyone who wants transparency about the pharmacy and oversight behind their meds, it will feel thin.
How the pricing actually works: flat per dose, then a step up
The headline rate is a starter offer, not your forever price, and it helps to understand the shape of it before you commit. The SimpleStart deal covers your first three months for $74 a month, billed as a single upfront payment for the quarter rather than month to month. After that starter window, semaglutide moves to a standard ongoing monthly rate, and tirzepatide sits at a higher ongoing rate of its own. None of those step-up numbers are hidden, but they are easy to miss when the marketing leads with the teaser figure, so budget for the real ongoing cost, not just the first quarter.
The genuinely useful wrinkle in OrderlyMeds' model is that pricing is flat across doses. The company is explicit about it: the price does not climb as your dose climbs. As one line on its site puts it, 'Does the price increase with the dose? No! All of our medication is available for the same price per dosage.' That matters because most people titrate upward over the first several months, and at many competitors your monthly bill creeps up alongside your dose. Here, the number you sign up at is the number you keep paying, which makes long-term budgeting genuinely predictable.
What is included in the price
OrderlyMeds bundles the things that are easy to forget when you compare GLP-1 programs on the sticker price alone. Per the company, your monthly fee covers:
- The telehealth doctor's visit and prescription, with no separate consult fee bolted on
- The compounded medication itself
- Syringes for self-injection
- Shipping to your door
That all-in structure is part of why the entry price reads as low as it does. Some rivals advertise a slim medication price and then add a membership or consultation charge on top; OrderlyMeds folds those into one figure. When you stack it against the roughly $170 category median, the value case is real, at least for the starter period.
The medications, and how they are dispensed
OrderlyMeds offers compounded semaglutide and compounded tirzepatide, the same two molecules behind the big brand-name GLP-1 drugs, prepared by a compounding pharmacy rather than the original manufacturer. There is no brand-name Wegovy, Ozempic, or Zepbound option here; this is a compounded-only program, which is exactly how it reaches these prices. Compounded medication is legal to prescribe through licensed pharmacies, but it is not FDA-reviewed the way a brand product is, so the quality of the specific pharmacy doing the work matters a great deal.
Where the transparency runs out
This is the part to read slowly. OrderlyMeds does not publicly name its compounding pharmacy, and we have no accreditation detail on file for whoever fills its prescriptions. For a compounded-medication program, that is the single most important fact a buyer would want, and its absence is the clearest mark against this provider. We also could not confirm which states OrderlyMeds serves; it does not disclose its coverage map, so you will need to verify availability for your own state during signup rather than assuming it operates where you live. To its credit, we found no FDA warning letters on file against OrderlyMeds, so there is no specific safety flag on record. But 'no red flag' is not the same as 'verified oversight,' and the documentation simply is not there to fully vet who is behind the medicine.
Who should choose OrderlyMeds, and who should skip it
Choose it if price is your deciding factor, you are comfortable with compounded GLP-1s, and you are willing to confirm the program details yourself before paying. The flat-per-dose model and all-inclusive starter price make it one of the cheapest credible on-ramps to treatment, especially for that first quarter.
Skip it if you want brand-name medication, if you need to know exactly which accredited pharmacy is compounding your dose, or if you would rather pay more for a provider that publishes its state coverage, support model, and refund terms up front. Patients who value documentation and hand-holding over the lowest number will be happier elsewhere.
Bottom line
OrderlyMeds is a price-first GLP-1 provider that delivers exactly what it advertises: an unusually cheap, all-inclusive, flat-rate starter program for compounded semaglutide and tirzepatide. The flat-dose pricing is a real, underrated advantage for anyone planning to titrate up. What holds it back is information, not price: an undisclosed pharmacy, no published accreditation, and an unclear state map mean you are trusting more and verifying less than you should have to. If you go in with eyes open, confirm coverage in your state, and treat the $74 figure as a starter rate rather than your permanent bill, it earns its place on a budget shortlist. See our scoring methodology for how we weigh price against transparency.
Shopping around? Telos Rx ($49/month) and bmiMD ($99/month) are the nearest alternatives to OrderlyMeds in our rankings.
Ready to start with OrderlyMeds?
Starting at $74/month. See current pricing and start your free consultation.
Alternatives to OrderlyMeds
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this OrderlyMeds review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with OrderlyMeds?
Starting at $74/month. See current pricing and start your free consultation.